Current Status

The Court held a hearing on August 2, 2018 to consider whether the Settlement should be approved and related matters. On August 6, 2018, the Court entered an order approving the Settlement and the Plan of Allocation.

 

On June 25, 2021, the Court entered a Final Judgment approving the Settlement; an order awarding attorneys’ fees and expenses; and an order approving the distribution of the Net Settlement Fund to eligible claimants.

For More Information

Please contact the Settlement Administrator:

Insulet Corp. Securities Litigation
c/o Analytics Consulting LLC
P.O. Box 2007
Chanhassen, MN 55317-2007

844-327-3154

info@InsuletSecuritiesLitigation.com

Please do not call the Court.

Welcome to the Insulet Corp. Securities Litigation Website.

 

The information contained on this web page is only a summary of information presented in more detail in the Settlement Notice. Because this website is just a summary, you should review the Notice for additional details.

This case, Insulet Corp. Securities Litigation, Civil Action No. 15-12345-MLW, brought in the United States District Court for the District of Massachusetts, arises out of allegations that Insulet Corp. (“Insulet”) and current or former Insulet officers Duane DeSisto, Allison Dorval, Brian Roberts and Charles Liamos, violated federal securities laws by making false and misleading statements about Insulet’s business, including with respect to the launch of its new flagship product, the Omnipod Eros insulin pump (“Eros”); the underlying demand for the Eros; and the nature and extent of alleged Eros-related manufacturing problems.

The Court-appointed Lead Plaintiffs, Arkansas Teacher Retirement System, the City of Bristol Pension Fund, and the City of Omaha Police & Fire Retirement System, on behalf of themselves and the other members of the Settlement Class (defined below), have reached a settlement with Defendants for $19,500,000 in cash that resolves all claims in the Action (the “Settlement”).

If you are a member of the Settlement Class, your rights will be affected and you may be eligible for a payment from the Settlement. The Settlement Class consists of:

all Persons who purchased Insulet common stock during the period commencing on May 7, 2013 through April 30, 2015, inclusive (the “Settlement Class Period”) and were damaged thereby, except for certain persons and entities who are excluded from the Settlement Class by definition (see Question 3 on page 6 of the Notice).

Please read the Notice to fully understand your rights and options.

The Court held a hearing on August 2, 2018 to consider whether the Settlement should be approved and related matters. On August 6, 2018, the Court entered an order approving the Settlement and the Plan of Allocation. On June 25, 2021, the Court entered a Final Judgment Approving Class Action Settlement and Order of Dismissal with Prejudice; a Memorandum and Order awarding attorneys’ fees and expenses; and an Order Approving Distribution Plan.

 

 LEGAL RIGHTS AND OPTIONS OF SETTLEMENT CLASS MEMBERS:
SUBMIT A CLAIM FORM The Court-ordered deadline for submission of Claim Forms was September 4, 2018.